Related Articles
Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas
Efficacy and survival outcomes of alectinib vs. crizotinib in ALK‑positive NSCLC patients with CNS metastases: A retrospective study
Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma
Simultaneous cytomorphological and multiparameter flow cytometric analysis of ALK-positive anaplastic large cell lymphoma in children
Effect of arsenic trioxide plus etoposide, solumedrol, high‑dose cytarabine and cisplatin chemotherapy on the treatment of relapsed or refractory ALK+ anaplastic large cell lymphoma